The University of Texas MD Anderson Cancer Center

12th Oncology Update: Advances and Controversies

January 17–20, 2014

Sheraton Steamboat HotelSteamboat Springs, Colorado

EDUCATIONAL METHODS Lectures - Question and Answer Sessions – Case Presentations – Meet the Professor Sessions

EVALUATION A course evaluation form will provide participants with the opportunity to comment on the value of the program content to their practice decisions, performance improvement activities, or possible impact on patient health status. Participants will also have the opportunity to comment on any perceived commercial bias in the presentations as well as to identify future educational topics.

ACCREDITATION/CREDIT DESIGNATIONThe University of Texas MD Anderson Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 25.50 AMA PRA Category 1 CreditsTM. Physicians should claim only credit commensurate with the extent of their participation in the activity.

ETHICS CREDITSSession VI presentations marked with an asterisk* have been designated by The University of Texas MD Anderson Cancer Center for a total of 2.50 AMA PRA Category 1 CreditsTM in medical ethics and/or professional responsibility.

CME CERTIFICATES AND ATTENDANCE VERIFICATION CERTIFICATESCertificates awarding AMA PRA Category 1 CreditTM or certificates documenting attendance will be distributed to participants when an individual departs the conference. To obtain a CME certificate, physicians must submit a completed evaluation questionnaire and a CME Verification Form.

Upon request, a record of attendance (certificate) will be provided on-site to other health care professionals for requesting credits in accordance with state nursing boards, specialty societies, or other professional associations.

12th Oncology Update:Advances and ControversiesJanuary 17-20, 2014Sheraton Steamboat Hotel • Steamboat Springs, Colorado

GOALThe goal of this program is to provide up-to-date information to the practicing physician regarding new advances in cancer care and treatment.

EDUCATIONAL OBJECTIVESAfter attending the conference, participants should be able to• Interpretinformationandincorporateintotreatmentthebestnoveltherapiesforsolid

tumors including Breast, Thoracic, Genitourinary, Gastrointestinal, Gynecologic/Peritoneal Malignancies, Head & Neck Cancer and Melanoma (Knowledge, Competence, Performance, Patient Outcomes)

•Utilizedifferentsurgical,radiation,andsystemictreatmentsincludingmolecularly targeted therapies for these cancers at various stages of disease to improve patient outcomes (Knowledge, Competence, Performance, Patient Outcomes)

• Incorporateappropriatesequenceforsurgical,radiation,andchemotherapeutic intervention for patients (Knowledge, Competence, Performance, Patient Outcomes)

• Illustrateandimplementtheoptimaltreatmentapproachwhengivenpatientscenariosrepresenting a range of stages, prognostic markers, and clinical presentations (Knowledge, Competence, Performance, Patient Outcomes)

• Interprettheclinicaleffectivenessofthedifferenttreatmentmodalitiesbasedupon efficacy and toxicity parameters (Knowledge, Competence, Performance, Patient Outcomes)

TARGET AUDIENCEThis program will be of interest to surgical oncologists, medical oncologists, radiation oncologists, diagnostic radiologists, pathologists, resident trainees, primary care physicians, advanced care practitioners, physician assistants, and nurses involved in oncologic care.

CONFERENCE CHAIRMANMerrick I. Ross, MDProfessor, Surgical OncologyMD Anderson

MD ANDERSON ORGANIZING COMMITTEERae Brana Reynolds, RN, MSNManager, Mid-Level Provider, Surgical OncologyCynthia A. ScottOffice Manager, Surgical OncologyConstance Tierney, CMP Manager, CME/Conference Management

The conference will begin with registration from 3:00-5:00 p.m. on Friday, January 17, 2014 followed by a session from 5:00-8:00 p.m. and a Welcome Reception from 8:00-10:00 p.m. All other sessions will run from 7:00 a.m.–Noon and 4:30–7:30 p.m. on January 18-20, 2014.

Program

Friday, January 17, 20143:00–5:00 p.m. Registration

Session I – Thoracic OncologyModerator: Stephen G. Swisher, MD

5:00 p.m. Current Recommendations for Lung Cancer Screening: Are We Making Any Progress? Stephen G. Swisher, MD

Treatment of Primary Lung Cancer: Surgery or Stereotactic Radiation – What About the Mediastinum?

David C. Rice, MD

Update on the Battle Trial: Are We Winning Any Battles? John V. Heymach, MD

Treating Lung Cancer with Immunotherapy and Radiation James Welsh, MD

Minimally Invasive Approaches to Esophageal Cancer Wayne L. Hofstetter, MD

Question and Answer/Case Presentations All Session Faculty

Keynote Presentatons: Cancer Immunotherapy: Checkpoint Inhibition, Melanoma and BeyondPatrick Hwu, MD

8:00-10:00 p.m. Welcome Reception

Saturday, January 18, 2014 6:30 a.m. Registration/Continental Breakfast

Session II – MelanomaModerator: Merrick I. Ross, MD

7:00 Prognostic Markers and Staging: What’s New? Jeffrey E. Gershenwald, MD

Current Status of Adjuvant Therapy: Any Changes On the Horizon? Merrick I. Ross, MD

Treatment of Stage IV Disease: The Art and Science of Decision Making Patrick Hwu, MD

Oncolytic Immunotherapy: Real Systemic Impact or Just Another Intra-Lesional Therapy?

Robert H. Andtbacka, MD

Reconstruction After Definitive Surgical Treatment David M. Adelman, MD

Question and Answer/Case Presentations All Session Faculty

9:30 Break

10:00 Meet the Professor – Melanoma Surgical and Medical Oncologists

Noon Session Adjourns

Session III – Breast CancerModerator: Kelly K. Hunt, MD 4:30 p.m. The Art and Science of Genetic Counselng in Breast Cancer Jennifer Litton, MD Current Controversies in the Management of DCIS Kelly K. Hunt, MD Selective Use of Adjuvant Therapy: Have the New Markers Helped? Funda Meric-Bernstam, MD Update on Triple Negative and Inflammatory Breast Cancer Jennifer Litton, MD Recurrent HER-2 Breast Cancer: Beyond Trastuzimab Vicente Valero, MD Cancer Vaccines: Is There a Future? ElizabethA.Mittendorf,MD Question and Answer/Case Presentations All Session Faculty

Keynote Presentation: Molecular Prognostic and Predictive Markers: Is Personalized Therapy Around the Corner?Funda Meric-Bernstam, MD

7:30 p.m. Session Adjourns

Sunday, January 19, 20146:30 a.m. Registration/Continental Breakfast

Session IV – UrologyModerator: Christopher G. Wood, MD

7:00 a.m. Management of the Primary Tumor in Advanced Prostate Cancer Brian F. Chapin, MD Localized Prostate Cancer: Who Really Needs Treatment? Neema Navai, MD Robotic Assisted Laparoscopic Radical Cystectomy with

Intracorporeal Diversion: Fact, Fad, or Fantasy? Jay B. Shah, MD Controversies in the Management of Stage 1

Non-Seminomatous Testicular Cancer Jose A. Karam, MD

Is there a Role for Neoadjuvant Therapy in the Management of Locally Advanced Renal Cell Carcinoma?

Christopher G. Wood, MD

Question and Answer/Case Presentations All Session Faculty

9:30 Break

10:00 Meet the Professor – Urology Faculty

Noon Session Adjourns

Session V – GI CancerModerator: Robert A. Wolff, MD

4:30 p.m. Systemic Therapy for Pancreas Cancer: Neo-Adjuvant or Adjuvant? Robert A. Wollf, MD

Xenograft Models in Pancreas Cancer: Impact on Future Therapies Jason B. Fleming, MD

Colon Cancer Prevention: Any Progress Made? Patrick Lynch, MD, JD

Radiation Therapy for Rectal Cancer: Routine or Selective Use? Christopher Crane, MD

Hepatocellular Cancer: Still a Death Sentence? Steven A. Curley, MD

Question and Answer/Case Presentations All Session Faculty

Keynote Presentation: Proton Therapy: Expensive Gimmick or Real Benefit?GU: Andrew K. Lee, MDHead & Neck: Steven J. Frank, MD

7:30 p.m. Session Adjourns

Monday, January 20, 20146:30 a.m. Registration/Continental Breakfast

Session VI – Outcomes and EthicsModerator: Merrick I. Ross, MD

7:00 a.m. Outcome Parameters in Cancer Care* Karl Y. Bilimoria, MD Quality of Life Assessment in Treating Patients with

Melanoma and Breast Cancer* Janice N. Cormier, MD Palliative Surgery: How Do We Measure Success?* Brian D. Badgwell, MD Cervical Cancer Vaccine: Efficacy and Should it be Mandatory? Kathleen M. Schmeler, MD Health Legislation/Policy Updates TBD Question and Answer – All Session Faculty

Keynote Presentation: Update on Retroperitoneal Sarcomas: From Bench Research to the PatientRaphael E. Pollock, MD

9:30 Break10:00 Meet The Professor – Sarcoma Faculty Noon Session Adjourns

Session VII – Head and Neck/BrainModerator: Michael E. Kupferman, MD 4:30 p.m. Epidemiology of HPV and Cancer Erich M. Sturgis, MD Update on HPV Related Head and Neck Cancer Michael E. Kupferman, MD Multidisciplinary Approach to Advanced Thyroid Cancer Jeffrey E. Lee, MD Management of Metastatic Brain Tumors: Surgery or Gamma Knife? Jeffrey Weinberg, MD Question and Answer – All Session Faculty

Session VIII – Gynecologic/Peritoneal MalignanciesModerator:MichaelFrumovitz,MD Using Social Media to Perform Research in Rare Tumors JenniferK.Burzawa,MD Multidisciplinary Management of Ovarian Cancer MichaelFrumovitz,MD Peritoneal Perfusion: Appendiceal Cancer and Beyond Richard Royal, MD Question and Answer/Case Presentations – All Session Faculty 7:30 p.m. Conference Adjournment

REGISTRATION INFORMATIONOn-site registration for the 12th Annual Oncology Update: Advances and Controversies, will open at 3:00 pm on Friday, January 17, 2014, and the conference will begin at 5:00 pm on Friday, January 17, 2014, followed by a Welcome Reception. The conference will adjourn at 7:30 pm on Monday, January 20, 2014. Advance registration is encouraged as space and materials are limited. Please see registration form for applicable fees.

The deadline for advance registration is January 3, 2014.

There are three ways to register:•MailtoCME/ConferenceManagement–Unit1381,TheUniversityofTexas

MD Anderson Cancer Center, P. O. Box 301439, Houston, TX 77230-1439.•Faxto713-794-1724•Registeron-lineatwww.mdanderson.org/conferences

We accept the following forms of payment:•Check(payablethroughU.S.banksonly)•Moneyorder•Creditcards(MasterCard,VISA,andAmericanExpress)•Cash(on-siteregistrationonly)

When registering on-line a receipt/confirmation letter will automatically be e-mailed to the e-mail address you list on the registration form. If you register by fax or mail a receipt/ confirmation letter will be sent to you within ten working days of receipt of your fee.

The conference registration fee includes the tuition, final program, continental breakfasts, coffee breaks, and welcome reception.

REFUND/CANCELLATION POLICYThe registration fee, minus a $50 administrative handling fee, is refundable if a written request is received on or before January 3, 2014. No refunds will be granted after that date. The request for a registration refund must include the tax identification number of the company or institution if registration was paid by a company or institution check.

For additional information, contact CME/Conference Management at 713-792-2223 or toll free at 866-849-5866.

The University of Texas MD Anderson Cancer Center has implemented a process whereby everyone who is in a position to control the content of an educational activity must disclose all relevant financial relationships with any commercial interest that could potentially affect the information presented. MD Anderson also requires that all faculty disclose any unlabeled use or investigational use (not yet approved for any purpose) of pharmaceutical and medical device products. Specific disclosure will be made to the participants prior to the educational activity.

The Department of CME/Conference Management reserves the right to cancel activities prior to the scheduled date, if low enrollment or other circumstances make it necessary. Each registrant will be notified by mail, e-mail, or the phone or fax numbers given on the registration form.

In case of activity cancellation, the liability of the Department of CME/Conference Management is limited to the registration fee. The Department of CME/Conference Management reserves the right to limit the number of participants in a program and is not responsible for any expenses incurred by an individual whose registration is not confirmed and for whom space is not available.

For additional information, contact CME/Conference Management at 713-792-2223 or 1-866-849-5866.

David M. Adelman, MDAssistant ProfessorPlastic Surgery

Brian D. Badgwell, MDAssistant ProfessorSurgical Oncology

Jennifer K. Burzawa, MDAssistant ProfessorGynecologic OncologyReproductive Medicine

Brian F. Chapin, MDAssistant ProfessorUrology

Janice N. Cormier, MDProfessor Surgical Oncology

Christopher Crane, MDProfessorRadiation Oncology

Steven A. Curley, MDProfessorSurgical Oncology

Jason B. Fleming, MDProfessorSurgical Oncology

Steven J. Frank, MDAssociate ProfessorRadiation Oncology

Michael Frumovitz, MDAssociate ProfessorGynecologic OncologyReproductive Medicine

Jeffrey E. Gershenwald, MDProfessorSurgical Oncology

John V. Heymach, MDChair & Associate ProfessorThoracic/Head & NeckMedical Oncology

Wayne L. Hofstetter, MDAssociate ProfessorThoracic & Cardiovascular Surgery

Kelly K. Hunt, MDProfessorSurgical Oncology

Patrick Hwu, MDProfessorMelanoma Medical Oncology

Jose A. Karam, MDAssistant ProfessorUrology

Michael E. Kupferman, MDAssociate ProfessorHead & Neck Surgery

Andrew K. Lee, MDProfessor Radiation Oncology

Jeffrey E. Lee, MDChair & ProfessorSurgical Oncology

Jennifer Litton, MDAssistant ProfessorBreast Medical Oncology

Patrick M. Lynch, MD, JDProfessor, Gastroenterology Hepatology & Nutrition

Funda Meric-Bernstam, MDProfessor, Surgical Oncology

Elizabeth A. Mittendorf, MDAssistant ProfessorSurgical Oncology

Neema Navai, MDAssistant ProfessorUrology

Victor G. Prieto, MD, PhDProfessorPathology Administration

David C. Rice, MDProfessor, Thoracic & Cardiovascular Surgery

Merrick I. Ross, MDProfessor Surgical Oncology

Richard Royal, MDAssociate ProfessorSurgical Oncology

Kathleen M. Schmeler, MDAssociate ProfessorGynecologic Oncology &Reproductive Medicine

Jay B. Shah, MDAssistant ProfessorUrology

Stephen G. Swisher, MDChair & ProfessorThoracic & Cardiovascular Surgery

Erich M. Sturgis, MDProfessorHead & Neck Surgery

Vicente Valero, MDChair Ad Interim & ProfessorBreast Medical Oncology

Jeffrey Weinberg, MDAssociate ProfessorNeurosurgery

James Welsh, MDAssistant ProfessorRadiation Oncology

Robert A. Wolff, MDChair Ad Interim & ProfessorInvestigational Cancer Therapeutics

Christopher G. Wood, MDProfessorUrology

MD AndersonFaculty

GuestFacultyRobert H. Andtbacka, MDAssistant ProfessorDivision of Surgical OncologyUniversity of Utah School of MedicineHuntsman Cancer InstituteSalt Lake City, Utah

Karl Y. Bilimoria, MDAssistant Professor, SurgeryNorthwestern UniversityFeinberg School of MedicineChicago, Illinois

Raphael E. Pollock, MDProfessor of SurgeryDirector of Surgical OncologyChief of Surgical ServicesThe Ohio State UniversityThe James Comprehensive Cancer CenterColumbus, Ohio

ACCOMMODATIONS• AblockofroomshasbeenreservedforconferenceattendeesattheSheraton Steamboat

Hotel, 2220 Village Inn Court, Steamboat Springs, Colorado.

• Earlyhotelreservationissuggested.

• Thehotelphonenumberis1-800-848-8877

•Website: https://www.starwoodmeeting.com/StarGroupsWeb/res?id=1309053046&key=7D2F9

•Whenyoumakereservations,besuretomentiontheMDAnderson12th Annual Oncology Update: Advances and Controversies Conference to be assured of receiving the special meeting rate of $239.00. Condos and suites are available. Call hotel for rates. Please add 11.65% state and local taxes.

• Reservations and deposits received after December 18, 2013, will be confirmed if space is available and at currently published hotel guest room rates.

Rooms are guaranteed 30 days prior to arrival by taking a full deposit of the entrie stay. Upon the taking of the deposit all reservations are unchangeable. If cancelled the deposit is non-refundable.

LIFT TICKETS/EQUIPMENT RENTAL• Ski rentals are available for the group at a 30% discount. The code for the group is #SHMD.

Website is: https://store.steamboat.com/estore_996/Default.aspx

• Liftticketdiscountis5%.Couponswillbeavailableatregistration.

GROUND TRANSPORTATIONThe Sheraton Steamboat Hotel is 22 miles from the Yampa Valley Regional Airport in Hayden (locator code: HDN) and is served by United, Delta, Northwest, and American Airlines. Transportation from the Yampa Valley Regional Airport is available by GO Alpine Airport Shuttle at $35.20/person one way or $55.00/person round trip. Advance reservations are strongly suggested, since walk-up passengers are boarded on a space available basis only. Reservations can be made on-line up to 48 hours beforehand at www.alpinetaxi.com or by phone at 1-800-343-7433.

SPECIAL ASSISTANCEContact the Department of CME/Conference Management at 713-792-2223 or 1-866-849-5866 if you have any special dietary or ADA accommodation needs.

Please let us know what specific topics, issues or questions you wish to see addressed or emphasizedinthisactivity.Faxore-mailCME/ConferenceManagement.Allresponseswillbe forwarded to the Program Chairs for consideration.

REG

ISTR

ATIO

N F

EES

12th

Onc

olog

y U

pdat

e: A

dvan

ces

and

Co

ntro

vers

ies,

Jan

uary

17–

20, 2

014

Phys

icia

ns 1

Pos

tmar

ked

befo

re 1

/3/1

4 ....

......

......

$550

.00

1 P

ostm

arke

d af

ter 1

/3/1

4 ....

......

......

...$6

00.0

0

MD

Ande

rson

Fac

ulty

1 P

ostm

arke

d be

fore

1/3

/14 .

......

......

...$3

50.0

0 1

Pos

tmar

ked

afte

r 1/3

/14 .

......

......

......

$375

.00

Fello

ws,

Phy

sici

an A

ssis

tant

s,Nu

rses

, Soc

ial W

orke

rs 1

Pos

tmar

ked

befo

re 1

/3/1

4 ....

......

......

$250

.00

1 P

ostm

arke

d af

ter 1

/3/1

4 ....

......

......

...$2

75.0

0

CO

NFE

RE

NC

E R

EG

IST

RA

TIO

N -

D1114

65/065

8

12th

Onc

olog

y Upd

ate:

Ad

vanc

es a

nd C

ontr

over

sies –

Janu

ary 1

7–20

, 201

4

TH

IS IS

NOT

A S

ELF-

MAI

LER

ADDR

ESS

TO:

12th

Onc

olog

y Up

date

: A

dvan

ces

and

Cont

rove

rsie

sDe

partm

ent o

f CM

E/Co

nfer

ence

Man

agem

ent–

Unit

1381

The

Univ

ersi

ty o

f Tex

as M

D An

ders

on C

ance

r Cen

ter

PO B

ox 3

0143

9, H

oust

on, T

X 77

230-

1439

or fa

x to

713

-794

-172

4

Mak

e ch

eck

or m

oney

ord

er p

ayab

le to

:Th

e Un

iver

sity

of T

exas

MD

Ande

rson

Can

cer C

ente

r

Last

Nam

e

Fi

rst

M

I

H

ighe

st D

egre

e

Depa

rtmen

t (in

clud

e bo

x no

.)

Sp

ecia

lty

Inst

itutio

n

Ph

ysic

ian

Stre

et

City

S

tate

/For

eign

Cou

ntry

/Zip

or M

ail C

ode

Dayt

ime

Phon

e (w

ith a

rea

code

)

Cel

l Pho

ne (w

ith a

rea

code

)

F

ax (w

ith a

rea

code

)

E-m

ail A

ddre

ss

Emer

genc

y Co

ntac

t

Pho

ne (w

ith a

rea

code

)

Char

ge th

e fo

llow

ing:

o

VISA

oM

aste

rCar

d

o

Amer

ican

Exp

ress

Cred

it Ca

rd N

umbe

r

Exp

iratio

n Da

te

Busi

ness

Uni

t D

epar

tmen

t

Fun

d Gr

oup

F

und

F

und

Type

PC

By

Pr

ojec

t

Ac

tivity

Cred

it Ca

rd H

olde

r Nam

e (F

irst/

Last

)

Cre

dit C

ard

Hold

er B

illin

g Ad

dres

s &

ZIP

Cod

e

AuthorizedSignatureREQU

IREDforcreditcardorIDTM

DAndersonEmployeeID

No.(REQUIRED)

IDT

Appr

over

Nam

e (F

irst/

Last

) ple

ase

prin

t

I

DT A

ppro

ver E

-mai

l

oYe

s

o

No

MD

And

erso

n In

terd

epar

tmen

tal T

rans

fer (

IDT)

No.

:

The University of Texas MD Anderson Cancer Center has implemented a process whereby everyone who is in a position to control the content of an educational activity must disclose all relevant financial relationships with any commercial interest that could potentially affect the information presented. MD Anderson also requires that all faculty disclose any unlabeled use or investigational use (not yet approved for any purpose) of pharmaceutical and medical device products. Specific disclosure will be made to the participants prior to the educational activity.

Agendas are subject to change because we are always striving to improve the quality of your educational experience. MD Anderson may substitute faculty with comparable expertise on rare occasions necessitated by illness, scheduling con-flicts, and so forth.

Photographing, audio taping and videotaping are prohibited.

Depa

rtm

ent o

f CM

E/Co

nfer

ence

Man

agem

ent -

Uni

t 138

1Th

e Un

iver

sity

of T

exas

MD

Ande

rson

Can

cer C

ente

r#1

7670

0/D1

1146

5/PS

1006

58PO

Box

301

439

Hous

ton,

TX

7723

0-14

39

Non

-Pro

fit O

rg.

U.S

. Pos

tage

P A

I D

Hou

ston

, TX

Per

mit

No.

705

2